Evolving landscape of targeted treatment options for HER2-positive gastric/gastroesophageal adenocarcinomas

Epistola R, Chao J, Lee J. Evolving landscape of targeted treatment options for HER2-positive gastric/gastroesophageal adenocarcinomas. Clin Adv Hematol Oncol. 2023 Jun;21(6):312-320. PMID: 37530637.


Related Posts